This month's your MiTeGen Hottest Tweets in SBDD come with highlights across all topics including si...
For October 2023, we have the Human Epidermal growth factor Receptor 3 (HER3) as the 'Clovertex Drug...
This month, your MiTeGen Hottest Tweets in SBDD tweets come in the wake of the Ozempic frenzy. The i...
In a previous discussion, we highlighted the Manual Plunge Cooler by MiTeGen and its potential to co...
September's Clovertex Target of the Month is GPR61 following Pfizer's recent publication concerning ...
Here are your MiTeGen Hottest Tweets in SBDD with DARPin scaffolds stealing the show cracking tough ...
In August 2023, the GABAA receptor is highlighted our 'Clovertex Target of the Month' as the drug ta...
In this edition of MiTeGen Hottest Tweets in SBDD, the biotech world is manic about incretin mimetic...
I’m excited to announce that cryoDuck is now working with Proteros, a real powerhouse in structure-b...
For July 2023, we focus our attention on the Adeno-Associated Virus serotype 9 (AAV9) as the 'Clover...